Clinical Trial Update: Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessed the efficacy and safety of insulin glulisine in adults with type 2 diabetes. The study, sponsored by Sanofi, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED